Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06937450

Traumatic Hemothorax Drainage and Daily Lavage: Pilot Study

Traumatic Hemothorax Treatment With 14-Fr Pigtail Catheters or Large Bore (~28Fr) Chest Tubes With Daily Irrigation: A Pilot Single-Arm Intervention Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

This HTX treatment study evaluates the effects of chest tube size and the benefits of daily irrigations on acute HTX. 20 acutely injured but stable trauma patients requiring a chest tube for HTX will be enrolled. Patients will be assigned a 28Fr or 14 Fr chest tube with serial lavage and drainage. The endpoints will be HTX volume (by CT scan), complications, additional interventions, hospital length of stay, chest tube duration, provider feedback, and patient-reported outcomes.

Detailed description

This hemothorax (HTX) treatment study will evaluate the effects of chest tube size and daily lavage on HTX management outcomes. A total of 20 stable trauma patients requiring a chest tube for HTX will be recruited and consented. These patients will then undergo either 28Fr or 14Fr chest tube placement, depending on the preference of the treatment team at the time of placement. The study will include 10 patients with each type of chest tube (28Fr and 14Fr). Daily lavage will then be performed at 24h and 48h post-placement. Patients will be compared to historical control patients from the trauma registry who received either 28Fr or 14Fr chest tube placement followed by an initial lavage only. The primary endpoint will be the need for additional interventions such as tPA, additional chest tubes, thoracoscopic surgery (VATS), or thoracotomy. Secondary endpoints will include X-ray appearance at 72 hours, volume of HTX on CT at 72 hours, procedural complications, development of empyema (safety endpoint), development of delayed bleeding (safety endpoint), hospital length of stay, chest tube duration, provider feedback, and patient-reported outcomes.

Conditions

Interventions

TypeNameDescription
DEVICECLR IrrigatorAll enrolled patients will have their hemothorax treated with a CLR device that allows for easy suction and irrigation through indwelling catheters,
PROCEDURESerial Lavage and DrainageThe current protocol is to do a singular lavage and drainage, this study will investigate the benefits of daily lavage.
DEVICE28 Fr Open Chest TubePatients will have a standard 28 Fr open chest tube or a percutaneous 14Fr chest tube placed.
DEVICEPercutaneous 14Fr Chest TubePatients will have a standard 28 Fr open chest tube, or a percutaneous 14Fr chest tube placed.

Timeline

Start date
2025-03-03
Primary completion
2026-08-01
Completion
2027-08-01
First posted
2025-04-22
Last updated
2025-04-22

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06937450. Inclusion in this directory is not an endorsement.